The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

36 articles for Y Zeng


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis of classical, three-carbon-bridged 5-substituted furo[2,3-d]pyrimidine and 6-substituted pyrrolo[2,3-d]pyrimidine analogues as antifolates.EBI
Duquesne University
Synthesis of classical, four-carbon bridged 5-substituted furo[2,3-d]pyrimidine and 6-substituted pyrrolo[2,3-d]pyrimidine analogues as antifolates.EBI
Duquesne University
Synthesis of classical and nonclassical, partially restricted, linear, tricyclic 5-deaza antifolates.EBI
Duquesne University
Effect of C9-methyl substitution and C8-C9 conformational restriction on antifolate and antitumor activity of classical 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines.EBI
Duquesne University
High affinity sialoside ligands of myelin associated glycoprotein.EBI
The Scripps Research Institute
Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity.EBI
Pfizer
Design and synthesis of orally-active and selective azaindane 5HT2c agonist for the treatment of obesity.EBI
Pfizer
Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3.EBI
Lilly Research Laboratories
Discovery of a Potent and Orally Bioavailable Xanthine Oxidase/Urate Transporter 1 Dual Inhibitor as a Potential Treatment for Hyperuricemia and Gout.EBI
HEC Research and Development Center
Synthesis and biological evaluation of triazolones/oxadiazolones as novel urease inhibitors.EBI
Jishou University
Discovery of Novel Phenoxyaryl Pyridones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with High Selectivity for the Second Bromodomain (BD2) to Potentially Treat Acute Myeloid Leukemia.EBI
China Pharmaceutical University
Discovery of novel amide derivatives as potent quorum sensing inhibitors of Pseudomonas aeruginosa.EBI
South China Agricultural University
Targeting EGFR degradation by autophagosome degraders.EBI
Jinan University
A novel BODIPY-based theranostic agent for EBI
Shanghai Institute of Materia Medica
Degradation of Cyclin-Dependent Kinase 9/Cyclin T1 by Optimized Microtubule-Associated Protein 1 Light Chain 3 Beta-Recruiting Coumarin Analogs.EBI
Shanghai Institute of Materia Medica
Synthesis and biological activity of 2-alkylbenzimidazoles bearing a N-phenylpyrrole moiety as novel angiotensin II AT1 receptor antagonists.EBI
China Pharmaceutical University
Development of MPS1 Inhibitors: Recent Advances and Perspectives.EBI
Guizhou University
Novel bioactive hybrid Celecoxib-HDAC Inhibitor, induces apoptosis in human acute lymphoblastic leukemia cells.EBI
The Affiliated Hospital of Southwest Medical University
Structure-based discovery of potent inhibitors of Axl: design, synthesis, and biological evaluation.EBI
Hunan Normal University
The one-pot synthesis of butyl-1H-indol-3-alkylcarboxylic acid derivatives in ionic liquid as potent dual-acting agent for management of BPH.EBI
Southern Medical University
GPR52 Antagonist Reduces Huntingtin Levels and Ameliorates Huntington's Disease-Related Phenotypes.EBI
Fudan University
Synthesis of N-[4-[1-ethyl-2-(2,4-diaminofuro[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid as an antifolate.EBI
Duquesne University
Monosaccharide Analogues of Anticancer Peptide R-Lycosin-I: Role of Monosaccharide Conjugation in Complexation and the Potential of Lung Cancer Targeting and Therapy.EBI
TBA
Tie-2 activators targeting the Schlemm's canalBDB
EyePoint Pharmaceuticals, Inc.
ALPHA PROTEIN KINASE 1 INHIBITORS AND METHODS OF USEBDB
Shanghai Yao Yuan Biotechnology Co.
Inhibiting agents for bruton's tyrosine kinaseBDB
Biogen Ma
1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteinsBDB
Incyte
Mcl-1 inhibitors and methods of use thereofBDB
Astrazeneca
Quinazolinones that inhibit the formation of tau oligomers and their method of useBDB
Oligomerix
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylaseBDB
Tes Pharma
Bruton's tyrosine kinase inhibitorsBDB
Zibo Biopolar Changsheng Pharmaceutical
Pyridine and pyrazine derivative for the treatment of CFBDB
Novartis
2,4,7-substituted thieno[3,2-d]pyrimidine compounds as protein kinase inhibitorsBDB
Korea Institute of Science and Technology
Aminopyrimidines as SYK inhibitorsBDB
Merck Sharp & Dohme
Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles.BDB
Schering-Plough Research Institute